OUTLOOK THERAPEUTICS LTD
Significant control: Outlook Therapeutics Nl B.V. (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Outlook Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Outlook Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
OUTLOOK THERAPEUTICS LTD is an active private limited company (company number 08179857) incorporated on 14 August 2012, registered in Guildford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 30 September 2025, showing net assets of £1,000. Net assets were unchanged on the prior period.
By net assets it sits in the upper half of 54 comparable companies in Surrey (median £1,000, upper quartile £121k).
Ownership and control
- Outlook Therapeutics Nl B.V.
- owns 75–100% of shares
- holds 75–100% of voting rights
- Outlook Therapeutics, Inc.
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 14 August 201214 yrs ago
- Next accounts due
- 30 June 2027in 247 days
- Confirmation statement due
- 28 August 2027in 306 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £1,000 | — | — | — | — | — | — |
| 30 September 2024 | £1,000 | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £1,000 at 30 September 2025
- Incorporated five or more years agoIncorporated 14 August 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 306 days
- Next accounts duein 247 days
- Accounts period endNet assets £1,000 · dormant accounts
- Accounts period endNet assets £1,000 · dormant accounts
- Incorporated
Similar companies in Surrey
- CREST PHARMA LTDLightwater · inc. Jan 2013
- HANSA BIOPHARMA LIMITEDGodalming · inc. Jan 2013
- MUCOSAL DIAGNOSTICS LIMITEDMidhurst · inc. Mar 2012
- CLINICOLOGY LTD.Guildford · inc. Oct 2011
- CLINICAL PHASE DEVELOPMENT LTDRedhill · inc. Jul 2011
- LGC GENOMICS LIMITEDGuildford · inc. Jun 2011
All companies incorporated on 14 August 2012 · in Aug 2012.
Reminders for OUTLOOK THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.